Key statistics
On Friday, Novocure Ltd (N2VC34:SAO) closed at 9.64, -27.79% below its 52-week high of 13.35, set on Jul 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.64 |
---|---|
High | 9.64 |
Low | 9.64 |
Bid | 5.01 |
Offer | 15.00 |
Previous close | 9.75 |
Average volume | 675.75 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 20 2024 14:41 BST.
More ▼
Press releases
- Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy
- Novocure Announces Planned CEO Transition
- Novocure to Participate in 2024 Wells Fargo Healthcare Conference
- Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
- Novocure Reports Second Quarter 2024 Financial Results
- Novocure to Report Second Quarter 2024 Financial Results
More ▼